Document is current

Article History

Received: 2 December 2020

Accepted: 23 June 2021

First Online: 13 July 2021

Declarations

:

: The study was approved by the Sunnybrook Research and Ethics board and all participants, or their caregivers when appropriate, provided written informed consent, in accordance with the Declaration of Helsinki.

: Not applicable.

: Dr. Black reports grants and personal fees from Eli Lilly, grants and personal fees from Novartis, grants from GE Healthcare, grants from Biogen, grants from Genentech, grants from Optina, grants, and personal fees from Roche, outside the submitted work.Dr. Masellis reports grants from Canadian Institutes of Health Research, during the conduct of the study; other from Associate Editor, Current Pharmacogenomics and Personalized Medicine, personal fees from Bioscape Medical Imaging CRO, personal fees from GE Healthcare, personal fees from UCB, grants from Canadian Institutes of Health Research, grants from Early Researcher Award, Ministry of Economic Development and Innovation of Ontario, grants from Ontario Brain Institute, grants from Sunnybrook AFP Innovation Fund, grants from Alzheimer’s Drug Discovery Foundation (ADDF), grants from Brain Canada, grants from Heart and Stroke Foundation Centre for Stroke Recovery, grants from Weston Brain Institute, personal fees from Novartis, personal fees from Henry Stewart Talks, other from Novartis, grants from Roche, grants from Washington University, grants from Teva, and others from Teva, outside the submitted work.The other authors report no disclosures relevant to the manuscript.